IBEX Technologies Inc V.IBT

Healthcare Biotechnology

IBEX Technologies Inc., through its wholly owned subsidiary, IBEX Pharmaceuticals Inc., manufactures and markets enzymes for biomedical use. IBEX Pharmaceutical Inc.’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The Company also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research. The Company has developed a proprietary expression for the production of its enzymes in Flavobacterium heparinum. This expression system allows for producing each glycosaminoglycan (GAG) enzyme separately from other enzymes therefore achieving the highest purity using a well-defined proprietary purification scheme. The Company operates in one industry segment: the production and sale of diagnostic products.

TSXV:IBT - Post by User

IBEX Technologies Inc > Ibex Peer Group Comparison

<< Previous

Bullboard Posts

Next >>

Post by guarantor1on Jan 11, 2022 8:55am

194 Views

Post# 34302875

Ibex Peer Group Comparison

From the 2022 Ibex Management Proxy Circular :

Peer Group

A comparison of remuneration with similar companies in the pharmaceutical industry (the “Peer Group”) was performed during 2020 by the Compensation Committee. The Peer Group was composed of the following companies:

- Antibe Therapeutics Inc.
- Kane Biotech Inc.
- Nuvo Pharmaceuticals Inc. - Relevium Technologies Inc.

- Pascal Biosciences Inc.
- Replicel Life Sciences Inc. - Revive Therapeutics Ltd.

What's really interesting in my opinion, is that Ibex is the only company with Positive Earnings.
Based on 2021 earnings of .05 cents @ share, IBT's P/E = 9.7.
Market Cap =$11.5M, compared to ATE $35M // KNE $17M //MRV $16M // RVV $97M,
and RLV, PAS, RP have lower Cap's